Cargando…

Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D(3) or lactosylceramide treatment to enhance fracture repair

BACKGROUND/OBJECTIVE: Cyp24a1-null mice deficient in 24,25(OH)(2)D(3) display impaired callus formation during the endochondral phase of bone fracture repair. The 24,25(OH)(2)D(3) metabolite acted by binding to the TLC domain containing 3B isoform 2 (TLCD3B2, previously named FAM57B2) effector prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martineau, Corine, Kaufmann, Martin, Arabian, Alice, Jones, Glenville, St-Arnaud, René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Speaking Orthopaedic Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270532/ https://www.ncbi.nlm.nih.gov/pubmed/32518749 http://dx.doi.org/10.1016/j.jot.2020.03.013

Ejemplares similares

Vitamin D and Diseases of Mineral Homeostasis: A Cyp24a1 R396W Humanized Preclinical Model of Infantile Hypercalcemia Type 1
por: St-Arnaud, René, et al.
Publicado: (2022)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy
por: Sasaki, Akiko, et al.
Publicado: (2022)

Elastin Peptides Signaling Relies on Neuraminidase-1-Dependent Lactosylceramide Generation
por: Rusciani, Anthony, et al.
Publicado: (2010)

The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease
por: Yu, Wen, et al.
Publicado: (2021)

Epigenetic regulation of the 1,25-dihydroxyvitamin D(3) 24-hydroxylase (CYP24A1) in colon cancer cells
por: Höbaus, Julia, et al.
Publicado: (2013)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes
por: Mishra, Sumita, et al.
Publicado: (2014)

Reversible Conduction Failure in Anti-lactosylceramide-antibody-positive Combined Central and Peripheral Demyelination
por: Harada, Masaya, et al.
Publicado: (2019)

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children
por: Filimoniuk, Aleksandra, et al.
Publicado: (2020)

Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry
por: Dei Cas, Michele, et al.
Publicado: (2023)

Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes
por: Chatterjee, Subroto, et al.
Publicado: (2021)

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease
por: Bosworth, Cortney, et al.
Publicado: (2012)

Serum 24,25-dihydroxyvitamin D level in general Korean population and its relationship with other vitamin D biomarkers
por: Kim, Hyun-Ki, et al.
Publicado: (2021)

THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
por: Brown, Jeremy, et al.
Publicado: (2023)

Diagnostic Aspects of Vitamin D: Clinical Utility of Vitamin D Metabolite Profiling
por: Jones, Glenville, et al.
Publicado: (2021)

Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling
por: Chun, Rene F., et al.
Publicado: (2012)

1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2014)

Simultaneous Quantification of 25-Hydroxyvitamin D(3) and 24,25-Dihydroxyvitamin D(3) in Rats Shows Strong Correlations between Serum and Brain Tissue Levels
por: Xue, Ying, et al.
Publicado: (2015)

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis
por: Nguyen, H. Bryant, et al.
Publicado: (2013)

Expression of nephronectin is enhanced by 1α,25‐dihydroxyvitamin D(3)
por: Hiranuma, Katsuhiro, et al.
Publicado: (2016)

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
por: Faye, Pierre Antoine, et al.
Publicado: (2019)

The Use of 1α,25-Dihydroxyvitamin D(3) as an Anticancer Agent
por: Marcinkowska, Ewa, et al.
Publicado: (2016)

25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2020)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats
por: Boyan, Barbara D., et al.
Publicado: (2016)

Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3
por: Halicka, H. Dorota, et al.
Publicado: (2012)

The relationship of 1,25-dihydroxyvitamin D and Vitamin D binding protein in periodontitis
por: Rafique, Sara, et al.
Publicado: (2019)

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019)

Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice
por: Yoshihara, Toru, et al.
Publicado: (2018)

NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH
por: St-Arnaud, René, et al.
Publicado: (2022)

8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D(3)-induced growth inhibition without affecting 1,25-dihydroxyvitamin D(3)-stimulated differentiation of primary mouse epidermal keratinocytes
por: Bollag, Wendy B, et al.
Publicado: (2004)

Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
por: Dusso, Adriana S
Publicado: (2011)

25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) Promote the Differentiation of Human Subcutaneous Preadipocytes
por: Nimitphong, Hataikarn, et al.
Publicado: (2012)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

Differential Metabolic Stability of 4α,25- and 4β,25-Dihydroxyvitamin D(3) and Identification of Their Metabolites
por: Mizumoto, Yuka, et al.
Publicado: (2023)

1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss
por: Zou, Min-shu, et al.
Publicado: (2010)

Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer
por: Zhang, Ting, et al.
Publicado: (2018)

Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
por: Jeffery, Louisa E., et al.
Publicado: (2018)

Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy
por: Zeng, Xiaoyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_975b81nklg6hmk0e6ragm22a8v